Drug profile · INN
bimatoprost
BIMATOPROST SANDOZ
bimatoprost (BIMATOPROST SANDOZ) is a prostanoid fp receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — bimatoprost
- US status
- approved
- Class
- Sensory organs (S01)
- Route
- OPHTHALMIC
- Patents
- 9
- Programs
- 6
- Data quality
- 0.89
Quick answer
bimatoprost (BIMATOPROST SANDOZ) is a prostanoid fp receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid FP receptor agonist
Primary target: Prostaglandin F2-alpha receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
-
CA 3244873
TRAITEMENT PRÉVENTIF DE LA MIGRAINE
granted -
WO 2023077094
TRAITEMENT D'UN TROUBLE DÉPRESSIF MAJEUR
granted -
US 2023130736
METHODS OF TREATING MIGRAINE
granted -
US 2022380379
PHARMACEUTICAL COMPOUNDS
granted -
US 2021387969
BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS
granted -
CA 3177686
COMPOSITIONS COMPRENANT DE LA TROPOELASTINE RETICULEE A DE L'ACIDE HYALURONIQUE ET LEURS PROCEDES D'UTILISATION
granted -
CA 3152006
TROPOELASTINE DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA CICATRISATION DE L'ACNE
granted -
WO 2020012244
TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AU MOYEN DE BRAZIKUMAB
granted -
WO 2019016609
TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES
granted
Frequently asked questions
What is bimatoprost?
bimatoprost (BIMATOPROST SANDOZ) is a prostanoid fp receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for bimatoprost?
BIMATOPROST SANDOZ is a marketed brand name for bimatoprost. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bimatoprost?
bimatoprost has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.